Kathrine Kronberg Jakobsen

Rigshospitalet

Papers

1

Total Citations

10

H-Index

1

About

Dr. Kathrine Kronberg Jakobsen is a leading surgical oncologist whose research centers on the treatment of oropharyngeal squamous cell carcinoma (OPSCC), with a particular focus on transoral robotic surgery (TORS). Her major contribution lies in demonstrating that TORS combined with neck dissection can achieve excellent oncologic outcomes while minimizing the need for adjuvant radiotherapy, thereby reducing treatment-related morbidity. Her landmark 2024 study, which has already garnered 10 citations, provides compelling evidence from a consecutive single-institution series spanning 2013 to 2020, showing that early-stage OPSCC patients can be effectively managed with low rates of additional therapy. This work is especially significant given the rising incidence of HPV-driven OPSCC and the growing imperative to de-escalate treatment without compromising survival. Dr. Jakobsen’s research directly addresses the critical balance between cancer control and quality of life, positioning her as a key voice in the paradigm shift toward minimally invasive surgical approaches. Her findings are shaping clinical guidelines and offering patients a less toxic alternative to traditional chemoradiotherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020
10 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Rigshospitalet

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago